Skip to content
Clinical Trials – home
Research site

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy

Poland Ul. Kornela Ujejskiego 75, 85-168 Bydgoszcz, Poland

  • 38 trials recruiting
  • Systemic lupus erythematosus · Psoriatic arthropathy · Sjogren's syndrome
  • Adults and children

About Specializations

Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy in Bydgoszcz, Poland specialises in clinical trials of conditions such as Systemic lupus erythematosus, Psoriatic arthropathy, Sjogren's syndrome, Chronic lymphocytic leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of research in gastroenterology, focusing on innovative treatments for Crohn's Disease and Ulcerative Colitis. The center's studies aim to improve patient outcomes through novel therapeutic approaches.

  • Crohn's Disease
  • Ulcerative Colitis

By exploring new drug combinations and treatment regimens, the center contributes significantly to the understanding and management of these chronic conditions.

Oncology

Specializing in oncology, the center conducts extensive research on various types of lymphomas and multiple myeloma. The focus is on developing targeted therapies that offer improved efficacy and safety profiles.

  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Multiple Myeloma

Through cutting-edge clinical trials, the center is advancing the treatment landscape for these hematological malignancies.

Rheumatology

The center is a leader in rheumatology research, with a strong emphasis on autoimmune diseases such as Rheumatoid Arthritis and Systemic Lupus Erythematosus. The research aims to enhance therapeutic strategies and improve patient quality of life.

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjögren’s Syndrome

By investigating novel biologics and small molecules, the center is paving the way for more effective treatments.

Cardiology

In the field of cardiology, the center is dedicated to improving outcomes for patients with acute coronary syndrome and heart failure. Research efforts focus on optimizing antithrombotic therapies and heart failure management.

  • Acute Coronary Syndrome
  • Heart Failure

The center's work is instrumental in developing safer and more effective cardiovascular treatments.

Hematology

With a strong focus on hematology, the center explores innovative treatments for Chronic Lymphocytic Leukemia and Paroxysmal Nocturnal Hemoglobinuria. The research aims to enhance therapeutic efficacy and patient outcomes.

  • Chronic Lymphocytic Leukemia
  • Paroxysmal Nocturnal Hemoglobinuria

Through rigorous clinical trials, the center is advancing the understanding and treatment of these complex blood disorders.

Immunology

The center is a pioneer in immunology, focusing on conditions such as Primary Immunodeficiency Diseases and Idiopathic Inflammatory Myopathies. Research efforts are directed towards developing novel immunomodulatory therapies.

  • Primary Immunodeficiency Diseases
  • Idiopathic Inflammatory Myopathies

By advancing the understanding of immune system disorders, the center is contributing to the development of more effective treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Kornela Ujejskiego 7585-168 BydgoszczPoland
Recruiting now
38 trials
Conditions studied
50

More sites in BydgoszczPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

111 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:NAVENIBART
  • Sponsor:Astria Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Medical University Of Gdansk
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Scleroderma Research Foundation
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Janssen - Cilag International
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Arsenic Trioxide
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.